[Federal Register Volume 72, Number 209 (Tuesday, October 30, 2007)]
[Notices]
[Page 61375]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-21311]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated June 7, 2007, and published in the Federal Register 
on June 20, 2007, (72 FR 34039), Cambrex Charles City, Inc., 1205 11th 
Street, Charles City, Iowa 50616, made application by letter to the 
Drug Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of Lisdexamfetamine dimesylate (1205), a basic class of 
controlled substance listed in schedule II.
    The company plans to manufacture the listed controlled substance 
for sale to its customers.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Cambrex Charles City, Inc. to manufacture the listed basic class of 
controlled substance is consistent with the public interest at this 
time. DEA has investigated Cambrex Charles City, Inc. to ensure that 
the company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with State and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 
21 CFR 1301.33, the above named company is granted registration as a 
bulk manufacturer of the basic classes of controlled substances listed.

    Dated: October 22, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E7-21311 Filed 10-29-07; 8:45 am]
BILLING CODE 4410-09-P